San Mateo, CA, United States of America

Fiona Hyland

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations by Fiona Hyland

Introduction

Fiona Hyland is a prominent inventor based in San Mateo, California. She has made significant contributions to the field of genomic data analysis, particularly in immuno-oncology. With a total of 14 patents to her name, her work is at the forefront of innovative methods for gene fusion detection and genomic data compression.

Latest Patents

Fiona's latest patents include groundbreaking methods for context-based compression of genomic data for immuno-oncology biomarkers. This method involves compressing the number of reads data for targeted genes in a gene expression assay performed on a test sample. The targeted genes are categorized based on their functional context, allowing for a more efficient analysis of genomic data. Additionally, she has developed methods for partner-agnostic gene fusion detection. This method amplifies a nucleic acid sample using a primer pool to produce multiple amplicons, which are then sequenced and analyzed to detect gene fusion events without prior knowledge of specific fusion partners.

Career Highlights

Fiona Hyland works at Life Technologies Corporation, where she continues to innovate in the field of genomic research. Her expertise and dedication have led to advancements that significantly impact the understanding of genetic markers in immuno-oncology.

Collaborations

Fiona collaborates with talented individuals such as Sowmi Utiramerur and Heinz Breu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Fiona Hyland's contributions to genomic data analysis and her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in immuno-oncology and gene fusion detection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…